Nano‐Immunoconjugates in Immune Checkpoint Blockade: A Dual Approach to Precision Immunotherapy and Real‐Time Imaging

Documenti analoghi

• Immune Checkpoint Activity and Prognostic Roles of TNFRSF8, CD160, and TNFSF9 in Primary and Brain Metastatic NSCLC
  di: Sun‐Jiang Liu, et al.
  Pubblicazione: (2026)
• Real‐World Survival Outcomes of Patients With High PD‐L1 Advanced NSCLC Who Received Chemoimmunotherapy Versus Immunotherapy
  di: Junipearl Cheng, et al.
  Pubblicazione: (2025)
• Penpulimab‐kcqx—A Breakthrough in Nasopharyngeal Carcinoma Immunotherapy and the Urgent Need for Global Access
  di: Muhammad Hassan Umrani
  Pubblicazione: (2025)
• Enhancing Diagnostic Precision in Breast Cancer Detection: A Digital Breast Tomosynthesis Workshop Approach for Clinicians in the Southeast Asian Population
  di: Phuong Dung (Yun) Trieu, et al.
  Pubblicazione: (2025)
• Clinical Outcomes of the POPCORN Study: Pharmacodynamics of Pre‐Operative PD1 CheckpOint Blockade and Receptor Activator of NF‐κB Ligand (RANKL) Inhibition in Non‐Small Cell Lung Cancer (NSCLC)—A Phase 1B/2 Trial
  di: Elizabeth Ahern, et al.
  Pubblicazione: (2026)